Sotabase

Career

· Senior Staff Solutions Engineer, HashiCorp2022–
· Staff Solutions Engineer, Global (Vault SME Leader), HashiCorp2021–
· Staff Solutions Engineer, West North America, HashiCorp2020–

Publications (0)

A Comparison of Immediate Angioplasty with Thrombolytic Therapy for Acute Myocardial Infarction
1993
1,999
cited
Predictors of in-hospital and 6-month outcome after acute myocardial infarction in the reperfusion era: the Primary Angioplasty in Myocardial Infarction (PAMI) trail.
Journal of the American College of Cardiology · 1995
322
cited
Comparison of in-hospital outcome in men versus women treated by either thrombolytic therapy or primary coronary angioplasty for acute myocardial infarction.
American Journal of Cardiology · 1995
173
cited
A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group.
New England Journal of Medicine · 1993
135
cited
Analysis of the relative costs and effectiveness of primary angioplasty versus tissue-type plasminogen activator: the Primary Angioplasty in Myocardial Infarction (PAMI) trial. The PAMI Trial Investigators.
Journal of the American College of Cardiology · 1997
117
cited
Implications of recurrent ischemia after reperfusion therapy in acute myocardial infarction: a comparison of thrombolytic therapy and primary angioplasty.
Journal of the American College of Cardiology · 1995
103
cited
A Prospective, Randomized Trial Comparing Combination Half‐Dose Tissue‐Type Plasminogen Activator and Streptokinase With Full-Dose Tissue‐Type Plasminogen Activator
Circulation · 1991
80
cited
Influence of acute myocardial infarction location on in-hospital and late outcome after primary percutaneous transluminal coronary angioplasty versus tissue plasminogen activator therapy.
American Journal of Cardiology · 1996
44
cited
Outcome of different reperfusion strategies in patients with former contraindications to thrombolytic therapy: a comparison of primary angioplasty and tissue plasminogen activator. Primary Angioplasty in Myocardial Infarction (PAMI) Investigators.
Catheterization and Cardiovascular Diagnosis · 1996
25
cited
901-1 A Prospective, Randomized Trial Evaluating Early Discharge (Day 3) without Non-invasive Risk Stratification in Low Risk Patients with Acute Myocardial Infarction: PAMI-2
1995
20
cited
A prospective, randomized trial comparing combination half dose tPA with streptokinase to full dose tPA in acute myocardial infarction: Preliminary report
1990
9
cited
1022-103 Does Primary Angioplasty Improve the Prognosis of Patients with Diabetes and Acute Myocardial Infarction?
1995
7
cited
MYOCARDIAL INFARCTION Analysis of the Relative Costs and Effectiveness of Primary Angioplasty Versus Tissue-Type Plasminogen Activator: The Primary Angioplasty in Myocardial Infarction (PAMI) Trial
2016
Sotabase